Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 23,404 | 14,667 | 6,620 | 914 | 50,030 |
| Cost of Goods | 481 | 254 | 308 | 48 | N/A |
| Gross Profit | 22,923 | 14,413 | 6,312 | 866 | N/A |
| Operating Expenses | 55,628 | 64,766 | 53,446 | 49,638 | 58,820 |
| Operating Income | -32,705 | -50,353 | -47,134 | -48,772 | -8,790 |
| Other Income | 109 | 106 | 142 | -1,599 | -13,611 |
| Pre-tax Income | -32,596 | -50,247 | -46,992 | -50,371 | -22,401 |
| Income Tax | 726 | 8 | 18 | 8 | 155 |
| Net Income Continuous | -33,322 | -50,255 | -47,010 | -50,379 | -22,556 |
| Net Income | $-33,322 | $-50,255 | $-47,010 | $-50,379 | $-22,556 |
| EPS Basic Total Ops | N/A | N/A | -0.37 | -0.40 | -0.05 |
| EPS Basic Continuous Ops | N/A | N/A | -0.37 | -0.40 | -0.05 |
| EPS Diluted Total Ops | N/A | N/A | -0.37 | -0.40 | -0.05 |
| EPS Diluted Continuous Ops | N/A | N/A | -0.37 | -0.40 | -0.05 |
| EBITDA(a) | $-32,017 | $-49,670 | $-46,432 | $-48,084 | $-17,339 |